Revolution Stock Price, News & Analysis
Company Description
Revolution (NASDAQ: RVMDW) is a publicly traded company in the Biological Products, (no Diagnostic Substances) sector.
RVMDW stock has gained 3548.4% over the past year. Shares last traded at $1.93.
On a trailing twelve-month basis, Revolution reported revenue of $0 with net income of -$1.1B and diluted earnings per share of $-5.95.
This page provides a comprehensive overview of RVMDW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Revolution (RVMDW) stock last traded at $1.93. Over the past 12 months, the stock has gained 3548.4%.
Latest News
SEC Filings
Revolution has filed 5 recent SEC filings, including 2 Form 3, 1 Form 4, 1 Form 144, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on March 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RVMDW SEC filings →
Financial Highlights
operating income reached -$1.2B, and net income was -$1.1B. Diluted earnings per share stood at $-5.95. The company generated -$897.7M in operating cash flow. With a current ratio of 7.14, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Revolution (RVMDW) currently stands at 2.7 thousand shares, up 98.4% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 69.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Revolution (RVMDW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.3 days.
RVMDW Company Profile & Sector Positioning
Revolution (RVMDW) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.